Experts call out the need for affordable breast cancer treatment during the launch of trastuzumab biosimilar in the Philippines
Pfizer has introduced a trastuzumab biosimilar to enable more Filipinos to have access to a more affordable treatment for HER2 positive breast cancer.
Pfizer Ranked as Leading Company in Asia for COVID-19 Response and Patient-Centric Approach by Asian Patient Groups
Pfizer is ranked 1st in Australia/New Zealand region and overall 2nd in Asia in its corporate reputation from a patient perspective